Status:
UNKNOWN
Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome
Lead Sponsor:
Assiut University
Conditions:
Nephrotic Syndrome Steroid-Resistant
Eligibility:
All Genders
2-18 years
Brief Summary
Childhood nephrotic syndrome is the most frequent glomerular disease that presents during childhood,primarily owing to a disturbed immune function.This disease is characterized by alterations in selec...
Detailed Description
Childhood nephrotic syndrome is the most frequent glomerular disease that presents during childhood,primarily owing to a disturbed immune function.This disease is characterized by alterations in selec...
Eligibility Criteria
Inclusion
- Nephrotic children aged from 2 to 18 that admitted to Pediatric Hospital.
Exclusion
- Congenital or infantile nephrotic syndrome
- Other kidney diseases
- Abnormal kidney function test
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03235128
Start Date
October 1 2017
End Date
October 1 2019
Last Update
August 2 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.